Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT. (Q36691125)

15 August 2017

title

Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT. (English)

1 reference

15 August 2017

1 reference

Andrei Iagaru

1

1 reference

15 August 2017

Rinat Masamed

series ordinal

2

1 reference

15 August 2017

Peter A Singer

series ordinal

3

1 reference

15 August 2017

Peter S Conti

series ordinal

4

1 reference

15 August 2017

publication date

1 March 2007

1 reference

Molecular Imaging and Biology

15 August 2017

published in

1 reference

15 August 2017

volume

9

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

72-77

1 reference

Role of nuclear medicine in the diagnosis and therapy of medullary thyroid carcinoma

15 August 2017

cites work

1 reference

12 December 2020

Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma

1 reference

12 December 2020

Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study

1 reference

12 December 2020

The radionuclide molecular imaging and therapy of neuroendocrine tumors

1 reference

12 December 2020

The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer

1 reference

12 December 2020

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

1 reference

12 December 2020

18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels

1 reference

12 December 2020

FDG-PET in thyroid cancer.

1 reference

12 December 2020

Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study

1 reference

12 December 2020

Cancer statistics, 2006

1 reference

12 December 2020

Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid

1 reference

12 December 2020

Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography

1 reference

12 December 2020

18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature

1 reference

12 December 2020

Determination of medullary thyroid carcinoma metastases by 201Tl, 99Tcm(V)DMSA, 99Tcm-MIBI and 99Tcm-tetrofosmin

1 reference

12 December 2020

Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

1 reference

12 December 2020

18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma

1 reference

12 December 2020

Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine

1 reference

12 December 2020

PET and [18F]-FDG in oncology: a clinical update

1 reference

12 December 2020

Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer

1 reference

12 December 2020

Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B

1 reference

12 December 2020

Diagnosis in medullary thyroid cancer with [18F]FDG-PET and improvement using a combined PET/CT scanner

1 reference

12 December 2020

10.1007/S11307-006-0072-1

Identifiers

DOI

1 reference

15 August 2017

1 reference